Fig. 5From: Momordica charantia nanoparticles potentiate insulin release and modulate antioxidant gene expression in pancreas of diabetic ratsa Effects of M. charantia nanoparticles on ALT. ALT activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. b Effects of M. charantia nanoparticles on AST. AST activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. c Effects of M. charantia nanoparticles on ALP. ALP activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) groupBack to article page